Education (Colleges & Universities)
Here's a look at documents from public, private and community colleges in the U.S.
Featured Stories
University of Michigan: Can North America Mine Enough Rare Earth Elements?
ANN ARBOR, Michigan, June 16 (TNSjou) -- The University of Michigan issued the following news:
* * *
Can North America mine enough rare earth elements?
In the quest to create a robust supply chain of rare earth elements necessary for the clean energy revolution and everyday modern conveniences, North America has enough deposits of sufficient quality to begin looking in its own backyard, according to a University of Michigan study.
Rare earth elements are critical components of many products in our lives, including cell phones, car batteries, computers, flat screen televisions and in the batteries
... Show Full Article
ANN ARBOR, Michigan, June 16 (TNSjou) -- The University of Michigan issued the following news:
* * *
Can North America mine enough rare earth elements?
In the quest to create a robust supply chain of rare earth elements necessary for the clean energy revolution and everyday modern conveniences, North America has enough deposits of sufficient quality to begin looking in its own backyard, according to a University of Michigan study.
Rare earth elements are critical components of many products in our lives, including cell phones, car batteries, computers, flat screen televisions and in the batteriesthat store energy generated by renewable sources. About half of rare earth elements mined today are used for magnets in products ranging from fighter jets to wind turbines and battery electric vehicles, the study shows.
The researchers, led by U-M scientists Stephen Kesler and Greg Keoleian, estimate that worldwide demand for rare earth minerals will increase from 91 kilotons in 2024 to 123 kilotons in 2030 and 150 kilotons in 2040. However, the U.S. only accounts for about 11% of rare earth element mining, while China accounts for about 70% of this mining.
Evaluating 28 sites across North America, the researchers found that the sites contain enough rare earth elements to produce more than the U.S. needs for the next few decades, but only some of the deposits can be mined economically.
"With this study, we are trying to give a framework of information that might allow a more systematic evaluation of deposits, and to avoid an overconcentration of support for deposits which might not, in the long run, be competitive," said Kesler, professor emeritus in the U-M Department of Earth and Environmental Sciences.
"Environmentally, we don't want to do any more mining than necessary, and if you have too much production, then the price drops and everyone goes out of business. This is a situation in which a little bit of government oversight in terms of funding and encouragement can help to develop a stable industry."
The study, supported by Ford Motor Co., is published in Resources, Conservation & Recycling.
Making the grade
To determine the quality of these mineral deposits, the researchers examined tonnage, grade and total rare earth oxide content at each site. Tonnage refers to how much rare earth-bearing rock is present in the ground, while grade refers to concentration of the targeted elements in the rock.
The researchers also evaluated what other minerals and elements might be present that could complicate the mining process. For example, thorium, a radioactive element, is often found in rare earth deposits and is costly to dispose of safely, Kesler said.
"Our results show that all of the deposits in North America, with the exception of the Mountain Pass mine in California that is already in operation, are of lower quality than those that are in operation in China and Australia. But that doesn't mean they can't be produced," Kesler said. "The bottom line is that the deposits are close enough in quality that they might be able to support a domestic supply chain with a little government support, particularly if the prices remain high. The increased costs of mining rare earths in a supply chain of this type might be offset by savings in other parts of the processing and manufacturing stages."
Kesler and Keoleian also characterized the types of rare earth elements available at each site. Rare earth elements are broadly categorized into two groups: light rare earth elements and heavy rare earth elements. Light rare earth elements are more abundant and are used in a wide range of products. Light rare earths have excellent magnetic properties while heavy rare earth elements are valuable because they improve the magnet's stability at high temperatures, Kesler said.
The researchers found that the sites in the United States contained mostly light rare earth elements, while the heavy rare earth elements were concentrated in Canada.
"For light rare earths, the U.S. could do a good job of supplying itself, and for heavy rare earths, we would do best to cooperate with Canada," Kesler said.
Why do we need to mine?
Until about the 1980s, the U.S. mined rare earth elements with regularity at Mountain Pass in California, but that mining declined as mining in China increased. In addition to developing domestic mine operations, it's important for the U.S. to establish its own processing infrastructure and fully integrated supply chain, said Keoleian, professor of sustainable systems at U-M's School for Environment and Sustainability. Previously, rare earth elements mined in the U.S. were exported to China for processing.
"One reason rare earth elements are classified as critical minerals is because of their vital importance for multiple industrial and technology applications as well as national defense," Keoleian said. "But they also pose a supply chain risk, and disruption of the supply chain could have significant economic and national security consequences. And they're essential inputs for the clean energy transition."
The study was conducted in conjunction with scientists at Ford Motor Co. Next, the researchers plan to examine the adequacy of the domestic rare earth supply for meeting demand for electric vehicles and other applications through 2050. That analysis is focusing on the U.S. deposits characterized in this study, their processing and the recovery rates of four rare earth elements--neodymium, praseodymium, dysprosium, and terbium--used in magnets.
Other co-authors include Christian Hitt and Jacob Cieply of U-M Center for Sustainable Systems and Hyung Chul Kim, Robert DeKleine and James Anderson of Ford Motor Company's Research and Innovation Center.
Study: Onshoring North American rare earth mining (DOI: 10.1016/j.resconrec.2026.109027)
* * *
Original text here: https://news.umich.edu/can-north-america-mine-enough-rare-earth-elements/
University of Maryland Baltimore: First in Region Innovative Cell Therapy for Synovial Sarcoma
BALTIMORE, Maryland, June 16 -- The University of Maryland Baltimore campus issued the following news:
* * *
First in Region Innovative Cell Therapy for Synovial Sarcoma
Katie Ghiardi
The University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) is the first in the Maryland, Delaware, Virginia, and Washington D.C. region to offer an innovative cell therapy treatment for patients with an advanced type of soft tissue cancer, known as synovial sarcoma. This single-infusion T-cell therapy, called TCR-T therapy, involves engineering a patient's own white blood cells to recognize and
... Show Full Article
BALTIMORE, Maryland, June 16 -- The University of Maryland Baltimore campus issued the following news:
* * *
First in Region Innovative Cell Therapy for Synovial Sarcoma
Katie Ghiardi
The University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) is the first in the Maryland, Delaware, Virginia, and Washington D.C. region to offer an innovative cell therapy treatment for patients with an advanced type of soft tissue cancer, known as synovial sarcoma. This single-infusion T-cell therapy, called TCR-T therapy, involves engineering a patient's own white blood cells to recognize andattack cancer cells.
TCR-T therapy is one of the first of its kind to be FDA approved for solid tumors. The patient's T-cells are modified to target proteins inside the cancer cell and then infused back into the patient. The cell manufacturing process is similar to CAR T-cell therapy, used to treat blood cancers. While CAR T therapy targets proteins on the surface of cancer cells, TCR-T is able to target proteins inside the harmful cells.
UMGCCC is a national leader in CAR T-cell therapy treatment and research, with an ongoing first-in-human clinical trial for B-cell lymphomas. The Cancer Center has its own cell-processing laboratory - the Fannie Angelos Cellular Therapeutics GMP Laboratory.
"We are proud to utilize our expertise and experience with CAR-T therapy to offer this novel cellular therapy to patients with treatment resistant synovial sarcoma," said Ariel Fromowitz, MD, Assistant Professor of Medicine at the University of Maryland School of Medicine (UMSOM) and a hematologist/oncologist at UMGCCC. "The patients we have treated so far have tolerated it well with no serious side effects. We are hopeful and optimistic that they will have durable responses to the treatment."
Synovial sarcoma is a rare form of cancer that occurs in the body's soft tissues, including the muscles. It tends to impact younger patients, with one third being diagnosed under the age of 30, according to the National Cancer Institute.
"Standard options for patients with chemotherapy-resistant synovial sarcoma are limited," said Aaron Ciner, MD, Assistant Professor of Medicine at UMSOM and medical oncologist at UMGCCC. "It is critical that we have this option for patients who are diagnosed with advanced disease or recur after surgery and progress after chemotherapy. We are optimistic that this treatment will lead to a better quality of life and outcomes for our patients."
So far, 2 patients have received TCR-T therapy at UMGCCC. Patients must have a specific genetic profile to be eligible for TCR-T and are monitored in the hospital during and after treatment.
"At UMGCCC, we continue to strive to meet the vision of the Greenebaum family that, "your zip code should not determine the outcome of your diagnosis,"" said Taofeek K. Owonikoko, MD, PhD, Executive Director of UMGCCC and the Kevin J. Cullen Distinguished Professor of Oncology at UMSOM. "We remain committed to bringing advanced treatments closer to home for Marylanders. Patients should not have to travel far to receive the life-saving treatments they need, and we are encouraged by the expansion of this treatment option for synovial sarcoma patients."
* * *
Original text here: https://www.umaryland.edu/news/archived-news/june-2026/first-in-region-innovative-cell-therapy-for-synovial-sarcoma.php
UCCS and CDOC Partner for De-escalation Training Initiative
COLORADO SPRINGS, Colorado, June 16 -- The University of Colorado issued the following news release:
* * *
UCCS and CDOC partner for de-escalation training initiative
Continuing a longstanding partnership, the UCCS College of Public Service (CPS) and the Colorado Department of Corrections (CDOC) have launched the Bureau of Justice Assistance (BJA) Virtual Reality (VR) Training Initiative, using VR to help improve Adult Parole and Community Supervision training.
Established with an $800,000 grant from the BJA, the training offers an immersive, 360 degree way for Community Parole Officers (CPOs)
... Show Full Article
COLORADO SPRINGS, Colorado, June 16 -- The University of Colorado issued the following news release:
* * *
UCCS and CDOC partner for de-escalation training initiative
Continuing a longstanding partnership, the UCCS College of Public Service (CPS) and the Colorado Department of Corrections (CDOC) have launched the Bureau of Justice Assistance (BJA) Virtual Reality (VR) Training Initiative, using VR to help improve Adult Parole and Community Supervision training.
Established with an $800,000 grant from the BJA, the training offers an immersive, 360 degree way for Community Parole Officers (CPOs)to practice their response to challenging situations and improve safety measures and decision making. UCCS researchers will evaluate the training and pair their findings with officer feedback and case-management data to further refine their resources for real-world situations.
"Our priority is the safety of our staff and the communities we serve," said Andre Stancil, Executive Director of the Colorado Department of Corrections, in the CDOC press release. "By focusing this VR grant on Parole, we are ensuring our officers can practice navigating complex human interactions and challenging situations in a safe, virtual space. This technology allows our staff to refine their professional judgment in a way that protects both the officer and those under supervision, and the public."
"This partnership between UCCS and CDOC demonstrates the power of combining cutting-edge research with real-world practice to strengthen officer preparedness and enhance safety," said CPS Dean Wells in the press release. "By leveraging immersive virtual reality training and rigorous field evaluation, we are helping ensure officers are equipped with effective de-escalation strategies while advancing our shared mission to improve outcomes in the field. The results of this collaborative, applied research will benefit CDOC and other states."
* * *
Original text here: https://news.uccs.edu/2026/06/15/uccs-and-cdoc-partner-for-de-escalation-training-initiative/
Texas A&M Engineering: Rethinking Safety in Real-world Industrial Systems
COLLEGE STATION, Texas, June 16 -- The Texas A&M University College of Engineering issued the following news:
* * *
Rethinking safety in real-world industrial systems
Atif Ashraf, a recent Ph.D. graduate in industrial and systems engineering, studies how frontline workers adapt in practice when safety procedures meet the realities of high-risk work.
By Emily Godsey, Contributor
Atif Ashraf did not set out to rethink how safety works in high-risk industries. But after years of working in process safety research, he kept running into a persistent gap between how systems are designed and how
... Show Full Article
COLLEGE STATION, Texas, June 16 -- The Texas A&M University College of Engineering issued the following news:
* * *
Rethinking safety in real-world industrial systems
Atif Ashraf, a recent Ph.D. graduate in industrial and systems engineering, studies how frontline workers adapt in practice when safety procedures meet the realities of high-risk work.
By Emily Godsey, Contributor
Atif Ashraf did not set out to rethink how safety works in high-risk industries. But after years of working in process safety research, he kept running into a persistent gap between how systems are designed and howwork actually unfolds in the field.
Ashraf is a recent Ph.D. graduate in the Wm Michael Barnes '64 Department of Industrial and Systems Engineering at Texas A&M University. Studying human factors, process safety and resilience engineering, he focuses on how frontline workers interact with procedures in complex environments and how those interactions often differ from formal expectations.
With a background in chemical engineering, Ashraf began his career at the Mary Kay O'Connor Process Safety Center, where he worked on technical solutions aimed at reducing industrial risk. That experience gave him strong technical grounding but also exposed something he could not ignore.
"What first sparked my interest in human factors, process safety and resilience engineering was the realization that frontline workers were often an afterthought in safety design," Ashraf said.
That observation shifted the direction of his research toward how work is performed, not just how it is designed on paper. He became interested in what happens when procedures meet real-world conditions such as time pressure, uncertainty and changing environments.
That interest led him to resilience engineering with a focus on how systems function successfully in practice, even when conditions are not predictable.
"Resilience engineering offered a different lens," Ashraf said. "Instead of viewing worker adaptations as problems to eliminate, it asks how workers successfully navigate complexity and how they make things work despite variability and uncertainty."
In his research, those adaptations are not rare exceptions. They are part of everyday work.
"My research has shown that workers seem to deviate from prescribed procedures in approximately one out of every three steps, yet they complete tasks successfully without adverse safety events," Ashraf said.
Rather than treating those deviations as mistakes, Ashraf studies them as signals of how adaptations and improvisations are realized in complex work settings. In many cases, he said, workers are actively managing tradeoffs that written procedures cannot fully anticipate.
His chemical engineering background plays a key role in how he approaches these questions, giving him both technical fluency and access to industrial environments where these systems operate.
"The combination of technical depth and human factors perspective is relatively rare, and I think it's a strength," Ashraf said.
At Texas A&M, Ashraf found an environment that allowed him to build on both sides of that expertise within the industrial and systems engineering department. He works closely with faculty, including his advisor Dr. Farzan Sasangohar, whose research focuses on human performance, cognition and safety in complex systems.
"Atif's research challenges conventional thinking about safety by showing that frontline worker adaptations are not failures of the system, but essential sources of resilience in complex industrial environments," Sasangohar said.
The academic environment encouraged independence in how Ashraf developed his ideas.
"What stands out most about the department's culture is the intellectual freedom my advisors gave me," Ashraf said. "I don't recall them ever saying an idea was bad or that I should go a different direction."
His work has been recognized through several honors, including selection as a Mirzayan Science and Technology Policy Fellow at the National Academies of Sciences, Engineering, and Medicine and recipient of both the Kingfar Award from the International Ergonomics Association and the Dieter W. Jahns Award from the Foundation for Professional Ergonomics.
"The award that stands out most is being selected as an Emerging Talent by the Resilience Engineering Association in 2021," Ashraf said. "That recognition came relatively early in my Ph.D. journey and validated that the research direction I was pursuing mattered to the broader resilience engineering community."
Outside of research, Ashraf serves as president of the Human Factors and Ergonomics Society student chapter. He is also involved in research communities connected to the Applied Cognitive Ergonomics Lab and resilience engineering collaborations, where he works alongside researchers studying human performance in complex systems.
Those roles, he said, reinforced the idea that impact often comes from structure and consistency rather than scale.
Looking ahead, Ashraf's goal is not just to study how work gets done, but to help reshape how it is understood in industry settings where the stakes are high, and the margin for error is small.
"We should be asking different questions," Ashraf said. "Not how do we eliminate adaptation, but how do we understand it."
Ashraf hopes his research will lead to safety systems that better reflect real conditions in the field and the decisions frontline workers make every day.
* * *
Original text here: https://news.engineering.tamu.edu/news/2026/06/15/rethinking-safety-in-real-world-industrial-systems/
Michigan Medicine: Emergency EEG Study Suggests Need for Faster Seizure Diagnosis and Care Options
ANN ARBOR, Michigan, June 16 (TNSjou) -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following news release:
* * *
Emergency EEG study suggests need for faster seizure diagnosis and care options
More research is needed on best care for emergency department patients without convulsions, but with altered mental states that could be a long-lasting seizure
-
Hospital emergency department teams often have to figure out what's going on with patients with mysterious and serious symptoms who can't communicate with their care team.
In some of those patients,
... Show Full Article
ANN ARBOR, Michigan, June 16 (TNSjou) -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following news release:
* * *
Emergency EEG study suggests need for faster seizure diagnosis and care options
More research is needed on best care for emergency department patients without convulsions, but with altered mental states that could be a long-lasting seizure
-
Hospital emergency department teams often have to figure out what's going on with patients with mysterious and serious symptoms who can't communicate with their care team.
In some of those patients,convulsing or flailing makes the diagnosis of a seizure relatively straightforward.
But a new study suggests that emergency teams need faster access to a kind of brain wave test that can reveal if a seizure is what's causing a patient to seem stuck in a trance, staring or confused and unable to communicate clearly for hours on end.
The test, called an electroencephalogram, or EEG, can reveal if the person is having a seizure that is difficult to see, or had a seizure recently.
This is particularly important for prolonged, repeated or continuous seizures, a condition called status epilepticus that can lead to brain damage and death.
But the new study in the International Journal of Emergency Medicine suggests that in patients whose emergency care teams ordered an EEG, it could take many hours from the time the patient arrived to the time they have the test.
In all, 9% of the patients in the study did have a seizure even though they were not convulsing; 40% of these patients were in non-convulsive status epilepticus which can cause serious brain damage if it's not reversed through medication.
But 72% of the entire group of 112 patients had another type of abnormal EEG reading, which could help their care team decide on treatment options.
The study shows the importance of more research to help guide emergency teams in the care of patients with altered mental status that might be seizure-related, says lead author Mariama Runcie, M.D., an emergency medicine physician at University of Michigan Health and research scholar at the U-M Institute for Healthcare Policy and Innovation.
"These are patients who appear to be sitting there 'stably' but something is terribly awry," said Runcie, a Clinical Instructor in the U-M Medical School's Department of Emergency Medicine.
"We don't have clear guidelines for emergency care of seizure beyond the first line of treatment, including guidance for when to use EEG. We hope this study will inform efforts to create such guidelines."
About the study
Runcie did the study with her former colleagues at Massachusetts General Hospital, where she did her emergency medicine training.
They analyzed data from 112 emergency patients whose records showed they had arrived at the ED with altered mental status and had an EEG ordered while they were still in the emergency department.
While just over half had been brought to the ED within six hours of starting to experience confusion or other symptoms, 21% had had symptoms for more than 24 hours before being brought in.
These pre-hospital delays are concerning, says Runcie, because prolonged untreated seizures can damage brain tissue and interfere with breathing.
But the time delay between when an EEG was ordered and completed is also concerning, especially considering the study's findings that most of those who got an EEG for altered mental status had some sort of abnormality, but it took on average 20 hours to get the EEG completed and get that information.
Need for more research and guidance
Getting information from EEGs more quickly might help speed diagnosis and treatment when a patient doesn't have a history of seizure, or a clear seizure exam like convulsing or even shaking a limb, the researchers suggest.
But getting rapid access to an EEG team and a neurologist to read the tracings, especially outside of major academic medical centers, may be very difficult, Runcie says.
Some manufacturers have begun selling rapid EEG machines that can be used in the ED, but the evidence for their use has been from manufacturer-funded studies.
Only one patient in the study had such an EEG.
That's why Runcie and her colleagues call for more research on the issue of emergency treatment for patients with altered mental status, suspected seizure, and no clear explanation for their condition such as drug reactions or dementia.
"When access to EEG is slow, patients may have anti-seizure medications started or modified by medical teams that don't have full information needed for decision-making," she said.
"The kinds of seizures and abnormalities that we saw on the EEGs for the patients in this study are the kinds that are much more difficult to diagnose with methods that do not include EEG."
She notes that clinical trials are now under way to test different approaches to treating neurological emergencies including seizures.
U-M is the clinical coordinating center for the SIREN Network, which is running several such studies, including the KESETT study that is testing a single or combination medication for patients with status epilepticus who don't respond to the initial standard therapy.
Such studies could help more patients avoid having to be put under general anesthesia to stop their seizure, which involves a breathing tube and intensive care hospital stay.
Similarly, more research on when EEG is appropriate and how to speed its use could help diagnose not only status epilepticus but other conditions.
Runcie also notes that it's important for patients who are already on anti-seizure medications to take them as directed, and to have information about their medication and diagnosis available in case they experience an emergency, such as in their wallet or on their phone's emergency card.
People who have been diagnosed with any type of brain tumor should also be aware they can experience seizures, and that seizures may not involve convulsions but can alter their mental state.
Five of the 10 patients diagnosed with EEG as having an active seizure causing their altered mental state had had brain tumors already diagnosed.
In addition to Runcie, the study's authors are IHPI member Robert Silbergleit, a Professor of Emergency Medicine at the University of Michigan, Fabio A. Nascimento of Washington University, and Harvard University researchers Neal Nolan, Olivia Yoo, Maura Kennedy, M. Brandon Westover and Joshua N. Goldstein, who is the study's senior author.
Citation: "EEG in patients with altered mental status in the emergency department," International Journal of Emergency Medicine. DOI: 10.1186/s12245-026-01200-6
* * *
Original text here: https://www.uofmhealth.org/health-lab/emergency-eeg-study-suggests-need-faster-seizure-diagnosis-and-care-options
Johns Hopkins: What Will It Take to Get a Bundibugyo Vaccine?
BALTIMORE, Maryland, June 16 -- Johns Hopkins University Bloomberg School of Public Health issued the following news release:
* * *
What Will It Take to Get a Bundibugyo Vaccine?
Three vaccine candidates for the Bundibugyo virus are in development, but it's not clear if or when they can be deployed in the current outbreak.
-
Projections from the CDC warn that, in the worst-case scenario, the current Ebola epidemic in the Democratic Republic of the Congo could rival the 2014-2016 West Africa outbreak that resulted in over 28,000 cases and more than 11,000 deaths. Global health organizations
... Show Full Article
BALTIMORE, Maryland, June 16 -- Johns Hopkins University Bloomberg School of Public Health issued the following news release:
* * *
What Will It Take to Get a Bundibugyo Vaccine?
Three vaccine candidates for the Bundibugyo virus are in development, but it's not clear if or when they can be deployed in the current outbreak.
-
Projections from the CDC warn that, in the worst-case scenario, the current Ebola epidemic in the Democratic Republic of the Congo could rival the 2014-2016 West Africa outbreak that resulted in over 28,000 cases and more than 11,000 deaths. Global health organizationsare racing to turn the tide on the crisis with a vaccine.
Ebola outbreaks are most commonly caused by the Ebola (or Zaire) virus, one of four orthoebolaviruses that can cause disease in humans. It is the only species with a vaccine: First developed in the 1990s and deployed in Guinea in 2015, the vaccine provides strong protection against the virus. But it cannot offer significant protection against the Bundibugyo virus driving today's outbreak.
Three vaccine candidates are now in development. But retreats from funding research into emerging pathogens by countries like the United States could complicate an already arduous vaccine licensing process.
In a Q&A adapted from the June 11 episode of Public Health On Call, Anna Durbin, MD, a professor in International Health and director of the Johns Hopkins Center for Immunization Research, explains what lies ahead for the vaccine candidates and what's limiting public health response to this outbreak.
Tell us about the three vaccines in development for the Bundibugyo virus.
CEPI, an organization that focuses on finding vaccines for emerging pathogens, and the global health organization IAVI are both funding efforts to develop vaccines for Bundibugyo. Two of the vaccines use viral vectors--harmless viruses that can replicate to produce a fragment of the ebolavirus that the immune system can then recognize when it encounters the real virus. One vaccine uses the vesicular stomatitis virus, as the Zaire Ebola vaccine does. The other uses an adenovirus vector.
The third one is an mRNA vaccine specifically for Bundabugyo, which uses a synthetic molecule encoded with the virus's genetic information to instruct the body's cells to begin producing the antigen. It differs from the other two in that it does not use another virus to deliver the instructions for producing the antigen.
However, these vaccines still have to be developed, produced, and evaluated for safety and then for efficacy. It will take months at a minimum before these vaccines could be utilized to help control this outbreak. But hopefully we will get those moving and have them available in the not-too-distant future so they could be evaluated during this outbreak.
Are there any effective treatments for Bundibugyo?
One treatment we have for Ebola Zaire is a monoclonal antibody, a lab-created defense protein that mimics those in our bodies and can be used to target a specific virus and fight off disease. Right now, we have an approved cocktail of three monoclonal antibodies for Ebola Zaire, and it's been shown that one of the monoclonal antibodies in that cocktail does have some activity against Bundibugyo. They may start testing that to see if they can treat or prevent some of the cases. But again, it's very early days. We don't have strong evidence that that will be enough.
There is another monoclonal antibody that was derived from a previous Bundibugyo outbreak patient. That has not been commercialized yet, though, so we don't have large-scale production.
Treatment also entails basic measures of how you care for Ebola patients: culturally aware communication around Ebola so people don't panic, treating patients not as pariahs but with compassion and care, and ensuring that healthcare workers are as protected as possible.
The success of the Ebola Zaire vaccine was a major public health achievement, so why are we starting at square one for a Bundibugyo vaccine?
It comes down to dollars, as so many things do. To get these vaccines from early development into a clinical product, into clinical trials, and then to licensure takes millions of dollars. And those dollars are public dollars. When people look at budgets, if the crisis isn't there, they say, "Why are we spending the money on this," not thinking forward to prevention.
We know that there is not a big financial market for these vaccines. We also know that outbreaks can occur very quickly, and we need vaccines ready to go when there is an outbreak.
* * *
Original text here: https://publichealth.jhu.edu/2026/what-will-it-take-to-get-a-bundibugyo-vaccine
Jackson College Launches 2 Blockchain Certificate Offerings
JACKSON, Michigan, June 16 -- Jackson College issued the following news:
* * *
College launches 2 blockchain certificate offerings
This fall, Jackson College will become the first college in the region to offer accredited courses and certificates in blockchain technology. The new programs reflect the growing importance of blockchain in today's workforce and provide students with opportunities to develop skills in one of the fastest-growing technology sectors.
Blockchain is a type of digital database shared across many computers and maintained collectively, making it secure and transparent.
... Show Full Article
JACKSON, Michigan, June 16 -- Jackson College issued the following news:
* * *
College launches 2 blockchain certificate offerings
This fall, Jackson College will become the first college in the region to offer accredited courses and certificates in blockchain technology. The new programs reflect the growing importance of blockchain in today's workforce and provide students with opportunities to develop skills in one of the fastest-growing technology sectors.
Blockchain is a type of digital database shared across many computers and maintained collectively, making it secure and transparent.Often associated with cryptocurrencies, blockchain now powers innovation across industries, including supply chain tracking, healthcare data, financial services, real estate transactions, digital identity verification, and voting systems.
Developed through a National Science Foundation Advanced Technological Education grant awarded to Professors Angel Fonseca and Dianne Hill, these programs introduce students to blockchain and its real-world applications.
"Blockchain is similar to an accounting ledger, but much more," Fonseca said. "It's quickly becoming a common business technology that is changing how companies operate."
Reinforcing its commitment to innovation and workforce development, Jackson College is pioneering access to financial aid-eligible credentials in one of today's fastest-growing technology sectors.
* Blockchain Foundations Certificate: Introduces students to blockchain technology, cryptography, smart contracts, and decentralized systems while building the analytical and digital skills needed for careers in emerging technologies.
* Blockchain Web3 Technician Certificate: Provides hands-on training in smart contract development, Web3 applications, and blockchain integration, preparing students for technical roles in the rapidly evolving digital economy. Web3 refers to the next generation of the Internet, designed to be decentralized and user-controlled through blockchain technology.
Learn more about these programs by visiting Jackson College's website at jccmi.edu or by contacting any Jackson College location (517.796.8425) to speak with an admissions representative. In the future, a non-credit module will be available free for businesses through JC's Corporate and Continuing Education programs.
* * *
Original text here: https://www.jccmi.edu/college-offers-blockchain-certificates/
